Pharmaceutical

CAS introduces stereoselective labeling in the CAS SciFinder® retrosynthesis tool – a first-of-its-kind capability in the world of scientific technology solutions

The new capability combines the industry-leading CAS Content Collection™ with cutting-edge technology and enables scientists to innovate with confidence COLUMBUS, Ohio,…

1 year ago

Top 10 Pharma Selects TrueMed for Advanced Counterfeit Drug Investigations

HELSINKI, Oct. 29, 2024 /PRNewswire/ -- TrueMed, a leading provider of anti-counterfeiting technology solutions, is proud to announce its new partnership…

1 year ago

AION Labs Launches New AI Startup to Accelerate Identification of Active Small Molecules for Drug Discovery

ProPhet, Newest Startup Launched by Israel-Based Venture Studio, Aims to Reduce Time and Cost of Finding Molecules for New Drug…

1 year ago

Laxxon Medical Names Lauren Chung PhD MBA as Chief Financial Officer

NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Laxxon Medical Corp., a leading pharma technology platform company focusing…

1 year ago

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024

SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q)…

1 year ago

Sensio Air Wins Prestigious Red Dot Award for Design Excellence

Innovative Airborne Pathogen Monitoring Device Recognized for Outstanding Design and FunctionalitySUNNYVALE, CA / ACCESSWIRE / October 29, 2024 / Sensio…

1 year ago

180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors

PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today…

1 year ago

Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio

FREIBURG, GERMANY / ACCESSWIRE / October 29, 2024 / Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos…

1 year ago

Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia

TORONTO, ON / ACCESSWIRE / October 29, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical…

1 year ago